Strix
26.1K

CVE-2026-42933

CRITICALCVSS 10/10EPSS 0.29%

Last modified

CVE-2026-42933 is a critical-severity vulnerability rated 10/10 on the CVSS scale. Pronetiqs IntraVUE versions 3.2.1a14 and prior have an unintended proxy or intermediary vulnerability which could allow an attacker to use an active proxy, which would bypass OT segmentation.. EPSS estimates a 0.29% chance of exploitation in the next 30 days.

Description

Pronetiqs IntraVUE versions 3.2.1a14 and prior have an unintended proxy or intermediary vulnerability which could allow an attacker to use an active proxy, which would bypass OT segmentation.

Metrics

CVSS 3.1
10/10

CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:C/C:H/I:H/A:H

CVSS 4.0
10/10

CVSS:4.0/AV:N/AC:L/AT:N/PR:N/UI:N/VC:H/VI:H/VA:H/SC:H/SI:H/SA:H/E:X/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X

EPSS Probability
0.29%

20.7th percentile

Probability of exploitation in the next 30 days. Learn more

Weakness Enumeration

Affected Software

Source: CNA advisory (CVE.org). NVD analysis pending.

VendorProductVersions
PronetiqsPanduit Intravue<= 3.2.1a14

References

Timeline

Published
Last Modified
Status
Deferred

Frequently Asked Questions

What is CVE-2026-42933?
Pronetiqs IntraVUE versions 3.2.1a14 and prior have an unintended proxy or intermediary vulnerability which could allow an attacker to use an active proxy, which would bypass OT segmentation.
How severe is CVE-2026-42933?
CVE-2026-42933 has a CVSS score of 10/10 (CRITICAL severity). The EPSS model estimates a 0.29% probability of exploitation in the next 30 days.
How do I fix CVE-2026-42933?
Check the vendor references and advisories linked above for patched versions and mitigation guidance. You can also run a Strix scan to test if your systems are affected.

How Strix Helps

Related CVEs from 2026

View all 2026CVEs →

Are you affected by CVE-2026-42933?

Run a free Strix scan to check your systems for this vulnerability.

Scan your code now

Source: NVD / NIST